Clinical trial
Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.
NCT00172198 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00172198 |
|---|---|
| Title | Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU. |
| Official title | A Prospective, Controlled, Randomized, Study Evaluating the Clinical Efficacy, Including Nutritional Status, Immune Function and Safety of Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU. |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Critical Ill Patients in SICU |
| Intervention type | Drug |
| Interventions | Omegaven 10% |
| Enrollment | 30 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: